Towards Healthcare
Insulin Market Overview | Growth | Share | 4.2% - CAGR

Insulin Market Size Envisioned at USD 41.63 Billion by 2033

The report covers Insulin Market Companies and Segments dominated by key players such as Eli Lilly, Novo Nordisk, Sanofi, Boehringer Ingelheim, Biocon, Lupin Ltd., Wockhardt Ltd., Becton, Dickinson and Company and B. Braun SE. Segmented by drug type, including rapid-acting, short-acting, intermediate-acting and premixed long-acting insulins sourced from either human insulin or insulin analogs. These applications caters such as Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes, administered through different delivery devices such as vials and syringes, insulin pens. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Insulin Market Assessment

Segmentation A (Drug)

  • By Product
    • Rapid-Acting (Fastest growing)
    • Short-Acting
    • Intermediate-Acting
    • Premixed Long-Acting (Dominated)
  • By Source
    • Human Insulin
    • Insulin Analog (Dominated)
  • By Distribution Channel
    • Hospital Pharmacies (Fastest Growing)
    • Retail Pharmacies (Dominated)
    • Online Pharmacies
  • By Application
    • Type 1 Diabetes
    • Type 2 Diabetes (Dominated)
    • Gestational Diabetes (Significantly growing)

Segmentation B (Delivery Device)

  • By Delivery Device
    • Insulin Pumps (Fastest)
    • Insulin Pens (Dominated)
    • Pen Needles & Syringes
    • Others
  • By Distribution Channel
    • Hospital Pharmacies (Fastest Growing)
    • Retail Pharmacies (Dominated)
    • Online Pharmacies
  • By Application
    • Type 1 Diabetes
    • Type 2 Diabetes (Dominated)
    • Gestational Diabetes (Significantly growing)

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Cross Segmentation A (Drug)

By Product

  • Rapid-Acting (Fastest Growing)
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Short-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Intermediate-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Premixed
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Long-Acting (Dominated)
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Source

  • Human Insulin
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Insulin Analog (Dominated)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Distribution Channel

  • Hospital Pharmacies (Fastest Growing)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Retail Pharmacies (Dominated)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Online Pharmacies
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Application

  • Type 1 Diabetes
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Type 2 Diabetes (Dominated)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Gestational Diabetes (Significantly growing)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

Cross Segmentation B (Delivery Device)

By Delivery Device

  • Insulin Pumps (Fastest Growing)
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Insulin Pens (Dominated)
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Pen Needles & Syringes
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Others
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Distribution Channel

  • Hospital Pharmacies (Fastest Growing)
    • By Delivery Device
      • Insulin Pumps
      • Insulin Pens
      • Pen Needles & Syringes
      • Others
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Retail Pharmacies (Dominated)
    • By Delivery Device
      • Insulin Pumps
      • Insulin Pens
      • Pen Needles & Syringes
      • Others
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Online Pharmacies
    • By Delivery Device
      • Insulin Pumps
      • Insulin Pens
      • Pen Needles & Syringes
      • Others
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Application

  • Type 1 Diabetes
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Type 2 Diabetes (Dominated)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa
  • Gestational Diabetes (Significantly growing)
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East and Africa

By Region

  • North America
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
  • Europe
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
  • Asia Pacific
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
  • Latin America
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes
  • Middle East and Africa
    • By Product
      • Rapid-Acting
      • Short-Acting
      • Intermediate-Acting
      • Premixed
      • Long-Acting
    • By Source
      • Human Insulin
      • Insulin Analog
    • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Application
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Gestational Diabetes

Company Profiles

  • Eli Lilly
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Novo Nordisk
  • Sanofi
  • Boehringer Ingelheim
  • Biocon
  • Lupin Ltd.
  • Wockhardt Ltd.
  • Becton, Dickinson and Company
  • B. Braun SE

Conclusion & Recommendations

  • Insight Code: 5101
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: January 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Human insulin is a peptide hormone that plays a crucial role in regulating blood sugar levels in the human body. The pancreas produces it and helps cells absorb glucose from the bloodstream, providing energy. In medical contexts, human insulin can refer to insulin derived from human sources or produced using genetic engineering techniques known as recombinant DNA technology. This synthetic insulin is used to treat diabetes to replace or supplement the insufficient natural insulin produced by the body.

Human insulin is available in various forms, including Regular Insulin (Short-Acting), Intermediate-Acting Insulin, Long-Acting Insulin and Premixed Insulin. The specific form and combination of insulin prescribed depend on an individuals diabetes management plan, lifestyle and medical needs.

The increasing prevalence of diabetes worldwide significantly influences the global insulin market, with a rising number of diagnosed individuals leading to an expanding demand for insulin products.

World Health Organization, Center for Disease Control and Prevention, MedlinePlus(.gov), Food and Drug Administration, HHS.gov., Diabetes Education Online.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515